News
Alembic Receives USFDA Clearance for Dapsone Gel and Oseltamivir Suspension
Alembic Pharmaceuticals announces USFDA final approval for Dapsone Gel, 5% and Oseltamivir Phosphate for Oral Suspension, 6 mg/mL.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Alembic Pharmaceuticals announces USFDA final approval for Dapsone Gel, 5% and Oseltamivir Phosphate for Oral Suspension, 6 mg/mL.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
